Why Choose EverydayMeds for Your Complete Treatment Journey?
1.7mg Wegovy vs Mounjaro: Your Complete Dose Escalation Journey
When comparing 1.7mg Wegovy vs Mounjaro, the most significant difference lies in their underlying mechanisms and how they fit into your complete treatment pathway. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. Both are prescription-only medicines requiring careful dose escalation, but their dosing schedules differ considerably. At EverydayMeds, we stock every dose of both medications, ensuring your treatment never gets interrupted regardless of which option your prescriber recommends.
The 1.7mg dose represents weeks 13-16 of your Wegovy journey—the penultimate step before reaching maintenance at 2.4mg from week 17 onwards. This is when many patients begin to see their most significant results, making it crucial to maintain consistency in supply and support. Our comprehensive stock levels mean you can plan your entire treatment trajectory with confidence, from initial 0.25mg starter doses through to long-term maintenance, all whilst receiving expert guidance from our GPhC-registered clinical team (#9012878).
Wegovy vs Mounjaro Pricing: Investment in Your Long-Term Success
The 1.7mg Wegovy pen costs £139.99 at EverydayMeds, representing excellent value as you approach maintenance dosing where results typically accelerate. For patients planning ahead, our Elevate Duo bundle combines 1.7mg and 2.4mg doses for £369.99, providing a seamless transition into maintenance without supply interruption. Returning customers benefit from the DOSE25 code applied at checkout, whilst new patients use FIRST40 to access these competitive prices. This pricing strategy reflects our commitment to supporting patients throughout their entire weight management journey, not just initial treatment phases.
When comparing 1.7mg Wegovy vs Mounjaro costs, both medications require similar investment levels, but Wegovy's storage advantages may reduce waste and improve convenience. Our flexible bundle options, including the Consistency 1.7mg bundle (two pens for £309.99), allow patients to stock up safely whilst maintaining optimal storage conditions. This approach particularly benefits patients who've experienced supply issues elsewhere or prefer the security of having backup medication during this crucial pre-maintenance phase.
Clinical Evidence Supporting 1.7mg Wegovy vs Mounjaro Effectiveness
In clinical trials, patients taking Wegovy alongside a reduced-calorie diet and increased physical activity achieved an average weight loss of approximately 15% at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The 1.7mg dose represents the penultimate escalation step, where patients often report improved appetite control and enhanced satiety compared to earlier doses. Mounjaro demonstrated comparable efficacy in its own clinical programme, though direct comparisons aren't possible due to different trial designs and populations.
Both medications require complete dose escalation from starter doses, meaning the 1.7mg comparison point represents significant treatment progression regardless of which option patients choose. The SELECT cardiovascular outcomes trial showed Wegovy reduced major cardiovascular events by 20% in eligible patients, adding important health benefits beyond weight management. Your prescriber can help determine which medication best suits your individual circumstances and medical history.
Understanding How Wegovy Works at 1.7mg Dosing
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural incretin hormone to reduce appetite and promote feelings of fullness after smaller meals. At the 1.7mg dose level, patients typically experience more pronounced appetite reduction compared to earlier escalation phases, as the therapeutic effect builds progressively. The medication works primarily on brain appetite centres, helping to reduce food cravings and making portion control feel more natural. This mechanism differs from traditional appetite suppressants, instead working with your body's existing satiety signals to support sustainable eating pattern changes. The once-weekly FlexTouch injection system ensures consistent medication levels throughout each seven-day period, maintaining steady appetite control effects.
Streamlined Ordering Process for All Wegovy Doses
EverydayMeds has simplified access to both 1.7mg Wegovy and Mounjaro through our comprehensive online service, starting with a 3-minute clinical assessment covering your medical history and treatment goals. Our prescribers typically complete reviews within 3 working days, with express 24-hour service available for urgent requirements. Once approved, all medications ship via next-day delivery using temperature-controlled cold-chain packaging to maintain product integrity. Our GPhC-registered pharmacy (#9012878) ensures full compliance with UK regulations whilst providing the convenience of doorstep delivery. The entire process eliminates traditional pharmacy visits, particularly valuable for patients managing busy schedules during their weight management programme.
Storage and Practical Considerations: Wegovy vs Mounjaro
A key practical advantage when comparing 1.7mg Wegovy vs Mounjaro lies in storage flexibility—Wegovy maintains potency for up to 6 weeks at room temperature once removed from refrigeration, compared to Mounjaro's 21-day limit. This difference proves particularly valuable for frequent travellers or patients with limited refrigeration access. Both medications require initial refrigerated storage between 2-8°C, but Wegovy's extended room temperature stability reduces waste from accidental temperature exposure. The FlexTouch pen system provides reliable dose delivery, whilst the once-weekly schedule improves adherence compared to daily medications. Proper rotation through your dose escalation schedule—0.25mg, 0.5mg, 1mg, 1.7mg, then maintenance 2.4mg—ensures optimal therapeutic progression regardless of which medication you choose.
Complete Dose Availability: Your Treatment Security Advantage
EverydayMeds' commitment to stocking all doses from 0.25mg through 2.4mg provides unmatched treatment continuity compared to pharmacies with limited inventory. This comprehensive approach proves particularly important at the 1.7mg stage, where patients are approaching maintenance and results are accelerating—supply interruptions could significantly impact progress. Our bundling options, including step-up combinations and consistency packs, allow forward planning that many patients find essential for treatment confidence.
Whether you choose Wegovy or Mounjaro, our complete dose range means you'll never need to search elsewhere or experience treatment gaps. This "one pharmacy for life" approach extends beyond simple convenience—it ensures consistent cold-chain handling, familiar ordering processes, and continuity of clinical oversight throughout your entire weight management journey, from initial prescription through years of maintenance therapy.
Next Steps: Securing Your Continuing Treatment
Ready to continue your weight management journey with confidence in supply and support? Visit our Wegovy collection at https://everydaymeds.co.uk/collections/wegovy to explore all available doses and bundling options suitable for your current treatment stage. New customers can apply code FIRST40 at checkout, whilst returning patients use DOSE25 for optimised pricing on their 1.7mg dose and beyond. Our clinical team remains available throughout your treatment progression, ensuring smooth transitions and addressing any concerns as you approach maintenance dosing. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which option best supports your individual treatment goals. Remember, successful weight management represents a long-term commitment, and choosing a pharmacy partner with complete dose availability ensures you're supported throughout the entire journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
